4//SEC Filing
Schreffler Gwendolyn 4
Accession 0001209191-22-001062
CIK 0001000229other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 5:53 PM ET
Size
8.7 KB
Accession
0001209191-22-001062
Insider Transaction Report
Form 4
Transactions
- Tax Payment
Common Shares
2021-12-31$22.31/sh−1,850$41,274→ 7,783 total - Exercise/Conversion
Common Shares
2021-12-31+4,700→ 9,633 total - Exercise/Conversion
Performance Shares
2021-12-31−4,700→ 0 totalExercise: $0.00→ Common Shares (4,700 underlying)
Footnotes (1)
- [F1]These awards vested at the end of a three-year performance period that began on January 1, 2019 and ended December 31, 2021 (the "Performance Period"). The restricted performance shares would vest only upon the Company's return on invested capital being in the top 75th percentile of the Company's peers as published by Bloomberg upon the close of the NYSE market on the last day of the Performance Period.
Documents
Issuer
CORE LABORATORIES N V
CIK 0001000229
Entity typeother
Related Parties
1- filerCIK 0001842114
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 5:53 PM ET
- Size
- 8.7 KB